Play Video

OIS

The Ophthalmology Innovation Summit (OIS) was conceptualized and developed by ophthalmologist/venture capitalist Emmett Cunningham of Clarus Funds now Blackstone Life Sciences. To make his vision for OIS a reality, Emmett enrolled legendary venture capitalists, Bill Link of Versant Ventures/Flying L Partners to Co-Chair the summits. The addition of experienced conference producer, Craig Simak brought the event to life in 2009.

Learn More

EVENT UPDATES

The Ophthalmology Innovation Source facilitates meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LEARN MORE

LEARN MORE

LEARN MORE

LEARN MORE
VIEW FULL 2021 CALENDAR

TRENDING AT OIS

Discover the latest trending news, podcasts, videos from OIS covering corporate leaders and innovators.

Venturing into Ophthalmology with ExSight
January 12, 2021
The Outlook on Getting Regulatory-Approved Bevacizumab to Market
January 5, 2021
A Vision for Building a Business with Jerry St. Peter of Eyevance
December 22, 2020
Retina Industry Leaders Impart Pearls of Wisdom for Finding Your Place in the Retina Space
December 16, 2020
Investing in the Future of Ophthalmology
December 8, 2020
Lessons learned for Conducting Clinical Trials in Challenging Times
January 12, 2021
Looking Ahead to 2021, Finding Value in 2020’s Lessons
January 5, 2021
Novartis Steps Up Digital Strategy for AMD Treatments and Patient Support
December 22, 2020
800-pound Gorilla Doesn’t Deter Investors in Ophthalmology Sector
December 16, 2020
With Hemera Deal, Janssen Continues Building Out Its Retina Portfolio: Glaucoma on the Horizon
December 8, 2020
Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs
August 18, 2020
Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery
April 29, 2020
OIS Index Rallies Back from COVID-Driven Decline
July 9, 2020
OIS Index Posts a Strong Finish to 2019
January 9, 2020
OIS Index Outperforms
December 4, 2019
OIS Index on Positive Upswing
November 6, 2019
OIS Index Deep in Bear Territory in Q3
October 2, 2019
Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Apply Today

The OIS All Stars of Ophthalmic Innovation

This is the inaugural ranking of individuals working to transform the current state of vision care. The nominees will be reviewed by a committee of OIS faculty, advisors and journalists. Once selected, the list of OIS All Stars will be published and widely promoted. Nominate your colleagues & peers here.

TESTIMONIALS

Why People Attend OIS

Daphne-Haim-Langford-PhD-OIS-Israel

TOM MITRO

PRESIDENT & COO

YARI MITCHELL

VP, GLOBAL MEDICAL AFFAIRS

JAG DOSANJH

SENIOR VICE PRESIDENT

SUBSCRIBE TO OUR NEWSLETTER

Get the Latest News Ophthalmic Innovation To Your Inbox.